Cancer: A computational disease that AI can cure

AI Magazine

Volumn 32, Issue 2, 2011, Pages 14-26

  Tenenbaum, Jay M ^c   Shrager, Jeff ^a,b  

^a CTO of CollabRx   (United States)

^b STANFORD UNIVERSITY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; MEDICAL COMPUTING; PATIENT TREATMENT;

DRUG COMBINATIONS; ELECTRONIC MEDICAL RECORD; HIGH QUALITY DATA; HIGH-DIMENSIONAL; MOLECULAR DIAGNOSTICS; PATIENT POPULATION; POTENTIAL TARGETS; RESEARCH OPPORTUNITIES;

DISEASES;

EID: 80051624353     PISSN: 07384602     EISSN: None     Source Type: Journal    
DOI: 10.1609/aimag.v32i2.2345     Document Type: Review

References (16)

1. Blanke, C. D.; von Mehren, M.; Joensuu, H.; Roberts, P. J.; Eisenberg, B.; Heinrich, M.; Druker, B.; Tuveson, D.; Dimitrijevic, S.; Silberman, S. L.; and Demetri, G. D. 2001. Evaluation of the Safety and Efficacy of an Oral Molecularly-Targeted Therapy, STI571, in Patients (Pts) with Unresectable or Metastatic Gastrointestinal Stromal Tumors (GISTs) Expressing c-KIT (CD117). Proceedings of the American Society of Clinical Oncology 20: (abstr 1). Alexandria, VA: American Society of Clinical Oncology.
2. Bonetta, L. 2010. Protein-Protein Interactions: Interactome Under Construction. Nature 468: 851-854.
3. Demetri, G. D. 2002. Targeting the Molecular Pathophysiology of Gastrointestinal Stromal Tumors with Imatinib. Mechanisms, Successes, and Challenges to Rational Drug Development. Hematology Oncology Clinics of North America 16(5): 1115-24. (Pubitemid 35462917)
4. Fiorentini, G.; Rossi S.; Lanzanova G.; Bernardeschi, P.; Dentico, P.; and De Giorgi, U. 2003. Potential Use of Imatinib Mesylate in Ocular Melanoma and Liposarcoma Expressing Immunohistochemical c-KIT (CD117). Annals of Oncology 14(5): 805. (Pubitemid 36621785)
5. Grove, A. 2005. Efficiency in the Health Care Industries: A View from the Outside. Journal of the American Medical Association (JAMA) 294(4): 490-492. (Pubitemid 41124183)
6. Haliban, R. 1991. Growth Factors and Tyrosine Protein Kinases in Normal and Malignant Melanocytes. Cancer Metastasis Review 10(2): 129-40.
7. Hodi, F. S.; Friedlander P.; Corless, C. L.; Heinrich, M. C.; Mac Rae, S.; Kruse, A.; Jagannathan, J.; Van den Abbeele, A. D.; Velazquez, E. F.; Demetri, G. D.; and Fisher, D. E. 2008. Major Response to Imatinib Mesylate in KIT-Mutate Melanoma. Journal of Clinical Oncology 26(12): 2046-51.
8. Kim, K. B.; Eton, O.; Davis, D. W.; Frazier, M. L.; McConkey, D. J.; Diwan, A. H.; Papadopoulos, N. E.; Bedikian, A. Y.; Camacho, L. H.; Ross, M. I.; Cormier, J. N.; Gershenwald, J. E.; Lee, J. E.; Mansfield, P. F.; Billings, L. A.; Ng, C. S.; Charnsangavej, C.; Bar-Eli, M.; Johnson, M. M.; Murgo, A. J.; and Prieto, V. G. 2008. Phase II Trial of Imatinib Mesylate in Patients with Metastatic Melanoma. British Journal of Cancer 99(5): 734-740.
9. Mauro, M. J., and Druker, B. J. 2001. STI571: Targeting BCR-ABL as Therapy for CML. The Oncologist 6(3): 233-238. (Pubitemid 32592214)
10. McDermott, U.; Downing, J. R.; Stratton, M. R. 2011. Genomics and the Continuum of Cancer Care. New England Journal of Medicine 364(4): 340-350.
11. Mocellin, S.; Shrager, J.; Scolyer, R.; Pasquali, S.; Verdi, D.; Marincola, F. M.; Briarava, M.; Gobbel, R.; Rossi, R.; and Nitti, D. 2010. Targeted Therapy Database (TTD): A Model to Match Patient's Molecular Profile with Current Knowledge on Cancer Biology. PLoS ONE 5(8): e11965. doi:10.1371/journal. pone.0011965
12. Pleasance, E. D.; Cheetham, R. K.; Stephens, P. J.; McBride, D. J.; Humphray, S. J.; Greenman, C. D.; Varela, I.; Lin, M.-L.; Ordóñez, G. R.; Bignell, G. R.; Ye, K.; Alipaz, J.; Bauer, M. J.; Beare, D.; Butler, A.; Carter, R. J.; Chen, L.; Cox, A. J.; Edkins, S.; Kokko-Gonzales, P. I.; Gormley, N. A.; Grocock, R. J.; Haudenschild, C. D.; Hims, M. M.; James, T.; Jia, M.; Kingsbury, Z.; Leroy, C.; Marshall, J.; Menzies, A.; Mudie, L. J.; Ning, Z.; Royce, T.; Schulz-Trieglaff, O. B.; Spiridou, A.; Stebbings, L. A.; Szajkowski, L.; Teague, J.; Williamson, D.; Chin, L.; Ross, M. T.; Campbell, P. J.; Bentley, D. R.; Futreal, P. A.; and Stratton, M. R. 2010. A Comprehensive Catalogue of Somatic Mutations from a Human Cancer Genome. Nature 463 (14 January): 191-196.
13. Shrager, J.; Tenebaum, J. M.; and Travers, M. 2011. Cancer Commons: Biomedicine in the Internet Age. In Collaborative Computational Technologies for Biomedical Research, ed. by S. Elkins, M. Hupcey, and A. Williams. New York: Wiley.
14. Sutton, R., and Barto, A. 1998. Reinforcement Learning: An Introduction. Cambridge, MA: The MIT Press.
15. Theobald, M.; Shah, N. H.; and Shrager J. 2009 Extraction of Conditional Probabilities of the Relationships between Drugs, Diseases, and Genes from PubMed Guided by Relationships in PharmGKB. Paper presented at the AMIA Summit on Translational Bioinformatics, San Francisco, March 15-17.
16. Vidwans, S.; Flaherty, K. T.; Fisher, D. E.; Tenebaum, J. M.; Travers, M. D., and Shrager, J. 2011. A Melanoma Molecular Disease Model. PLoS ONE 306(3): e18257. doi:10. 1371/journal.pone.0018257.